Drug Shortage Report for FAMOTIDINE OMEGA -(WITH PRESERVATIVE,BENZYL ALCOHOL)
Report ID | 202613 |
Drug Identification Number | 02247745 |
Brand name | FAMOTIDINE OMEGA -(WITH PRESERVATIVE,BENZYL ALCOHOL) |
Common or Proper name | Famotidine Injection |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | FAMOTIDINE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 x 20 mL vial / fiole |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-09-18 |
Estimated end date | 2024-04-23 |
Actual end date | 2024-04-22 |
Shortage status | Resolved |
Updated date | 2024-04-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2023-08-21 | French | Compare |
v1 | 2023-08-21 | English | Compare |